SL1009 (sodium dichloroacetate)

Name: SL1009 (sodium dichloroacetate) in Pyruvate dehydrogenase complex deficiency: Generic, brand name and therapeutic class of product
Published: 2026-09-14T15:39:06-04:00

Pyruvate dehydrogenase complex deficiency

Manufacturer: Saol Therapeutics
Regulatory submission: NDA resubmitted June 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Generic, brand name and therapeutic class of product

2 evidence topics · 2 sources

Manufacturer: Saol Therapeutics

“Sponsor: Saol Therapeutics Inc.” (opens the source at this quote in a new tab)

Development code and product name

“SL1009, Sodium Dichloroacetate Oral Solution (DCA)” (opens the source at this quote in a new tab)